Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2026-01-29 @ 4:00 PM
Study NCT ID:
NCT01011920
Status:
COMPLETED
Last Update Posted:
2017-08-23
First Post:
2009-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma
Sponsor:
International Extranodal Lymphoma Study Group (IELSG)
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IELSG32
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None